CNH Industrial vs Deere
CNH and DE side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CNH and DE compare
Deere is the larger company, worth 13 times as much as CNH Industrial ($182B against $14.6B).
On earnings, Deere is cheaper: it trades at 37.5× trailing earnings, against 47.0× for CNH Industrial.
Deere grew revenue faster over the last twelve months (8.0% versus 0.64% for CNH Industrial).
Deere keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with 1.7% at CNH Industrial.
Both pay dividends: CNH Industrial yields 0.85% and Deere 0.96%.
Deere scores higher on the StockData Score (11 against 7 for CNH Industrial), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CNH | DE |
|---|---|---|
| Size and price | ||
| Market cap | $14.6B | $182B |
| Share price | $11.76 | $675.48 |
| Change, 1 year | 10.7% | 42.7% |
| Change, 5 years | −33.4% | 90.2% |
| Beta (5Y) | 0.91 | 0.80 |
| Employees | 34K | 73K |
| StockData Score | ||
| Total score | 7 | 11 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 4 (better) | 2 |
| Dividend score | 2 | 4 (better) |
| Valuation | ||
| P/E | 47.0× | 37.5× (better) |
| P/S | 0.8× (better) | 3.8× |
| P/B | – | 6.5× |
| EV/EBITDA | – | 16.3× |
| P/FCF | – | 30.2× |
| FCF yield | – | 3.3% |
| Fair value | $7.93 | $454.94 |
| Margin of safety | −48.4% (better) | −48.5% |
| Growth | ||
| Revenue growth (TTM) | 0.64% | 8.0% (better) |
| Revenue growth, 5Y average | 4.1% | 5.2% (better) |
| Net income growth (TTM) | −62.2% | −6.4% (better) |
| EPS growth (TTM) | −61.5% | −5.9% (better) |
| EPS growth, 5Y average | – | 16.3% |
| Profitability | ||
| Gross margin | 30.6% | – |
| Net margin | 1.7% | 10.2% (better) |
| FCF margin | – | 12.5% |
| Return on equity | – | 18.3% |
| Financial health | ||
| Debt / equity | – | 0.61 |
| Net debt / EBITDA | – | 0.70 |
| Altman Z-score | 1.04 | 2.63 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.85% | 0.96% (better) |
| Payout ratio | 44.7% | 36.0% |
| Years of dividend growth | 0 | 5 (better) |
| Dividend growth, 5Y average | – | 15.8% |
| Buyback yield | – | 0.38% |
| Shareholder yield | 0.85% | 1.3% (better) |
| Ownership | ||
| Held by institutions | 72.8% | 75.4% |
| Held by insiders | 30.0% | 0.16% |
| Insider net buying, 12 months | $210K (better) | −$55.9M |
| Superinvestors holding | 3 | 4 (better) |
| Short interest, % of float | 5.9% | 2.1% |
Go deeper
- CNH stock overview
- CNH income statement
- CNH valuation and score
- DE stock overview
- DE income statement
- DE valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.